Efficient, low-energy chemical synthesis using enzymes for biocatalysis
Chemical synthesis and manufacture can be an incredibly energy-intensive and polluting industry. This is because many reactions require very high temperatures and/or extreme conditions, along with the use of many toxic reagents for the right chemistry to take place. There is an ever-increasing interest in finding milder reactions and alternative catalysts to produce many of the chemicals we need for pharmaceuticals, healthcare, and other speciality applications.
Professor Thomas Moody, Vice President of Technology Development and Commercialization at Almac Sciences, UK, has been developing new reaction alternatives, including the use of biocatalysts, to achieve highly selective reaction outcomes under more environmentally friendly conditions.
Download the article to find out more.
View Resource
Almac API, Chemical Development, Analytical & Solid State Services
Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).
We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.
We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.
Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.